Peptide Therapeutics Market
Peptide Therapeutics Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Peptide Therapeutics Market Size and Growth
The global peptide therapeutics market is expected to reach a value of $46.6 billion by 2027, with a compound annual growth rate of 8.3%. Factors driving growth include increasing prevalence of chronic diseases, advancements in peptide drug delivery systems, and rising investments in research and development. Key players include Novo Nordisk, Teva Pharmaceuticals, and Sanofi.
Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Sanofi
◍ Teva
◍ Novo Nordisk
◍ Takeda
◍ Eli Lilly
◍ AstraZeneca
◍ Novartis
◍ AbbVie
◍ Ipsen
◍ Ferring
◍ Merck
◍ The Medicines
◍ J & J
The peptide therapeutics market is highly competitive with companies like Sanofi, Teva, Novo Nordisk, Takeda, Eli Lilly, AstraZeneca, Novartis, AbbVie, Ipsen, Ferring, Merck, The Medicines, and J & J leading the way. These companies develop, manufacture, and market peptidebased drugs to treat various diseases, contributing to the market's growth.
- Sanofi: $37.3 billion
- Novo Nordisk: $16.8 billion
- Eli Lilly: $24.4 billion Request Sample Report
Market Segmentation
By Application
Cancer
Metabolic Disorders
Central Nervous System
Other
Request Sample Report
By Product
Injection
Oral
Other
◍
◍
◍
◍
◍
◍
◍
Market Growth
Request Sample Report
$ X Billion USD
THANK YOU Email : sales@reportprime.com USA : +1 507 500 7209 Website : https://www.reportprime.com/ Request Sample Report Contact US Our Clients